Aethlon Medical (AEMD) Stock Price, Quote & News

Company Profile

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

Industry: Medical Devices

Sector: Healthcare

Phone: 619 941 0360

Fax: 619 941 0361

Website: www.aethlonmedical.com

Address:

11555 Sorrento Valley Road, Suite 203, San Diego, United States

Vikingsstrade Oct. 3 at 7:34 PM

$DUO $BOLT $AEMD $INAB Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve!

0 · Reply

DougieFreshPicks Oct. 3 at 5:58 PM

$ELPW $AEMD $FRGT Here is the Night Note penny and small caps from last night 🎯

0 · Reply

smoothest06 Oct. 3 at 3:35 PM

$AEMD

0 · Reply

FCGEnterprises Oct. 3 at 12:08 PM

$AEMD lets go today $1 and up

0 · Reply

smoothest06 Oct. 3 at 1:23 AM

$AEMD

0 · Reply

MoonCowBoy Oct. 3 at 12:43 AM

$AEMD $INAB $OGEN $AGMH :

0 · Reply

Bazzzigar Oct. 2 at 6:58 PM

$AEMD

0 · Reply

1Spartantrade1 Oct. 2 at 6:38 PM

Massive merger news 3 days ago on NITO! NITO has a low share count like TTNP (BTTC) does. TTNP ran 400% today. Can NITO also run 400%? Make sure to take profits. Lets see if NITO halts up today when people realize. $AEMD $INAB $OGEN $AGMH 🚀

0 · Reply

Condemor Oct. 2 at 5:35 PM

$AEMD watchout if breaks 0.81

0 · Reply

smoothest06 Oct. 2 at 5:24 PM

$AEMD PRESSURE

0 · Reply

Aethlon Medical Announces Pricing of $4.5 Million Public Offering

Sep 3, 2025, 8:01 AM EDT - 4 weeks ago

Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC)

Aug 13, 2025, 8:01 PM EDT - 7 weeks ago

Aethlon Medical, Inc. (AEMD) Q1 2026 Earnings Call Transcript

Aug 13, 2025, 4:15 PM EDT - 7 weeks ago

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update

Aug 5, 2025, 8:01 AM EDT - 2 months ago

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025

Jul 15, 2025, 8:01 AM EDT - 2 months ago

Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort

Jun 26, 2025, 7:35 PM EDT - 3 months ago

Aethlon Medical, Inc. (AEMD) Q4 2025 Earnings Call Transcript

Jun 26, 2025, 4:15 PM EDT - 3 months ago

Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update

Jun 20, 2025, 8:01 AM EDT - 3 months ago

Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025

Jun 18, 2025, 8:01 AM EDT - 3 months ago

Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial

Jun 9, 2025, 8:01 AM EDT - 4 months ago

Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes

May 14, 2025, 8:01 AM EDT - 5 months ago

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma

Mar 10, 2025, 8:01 AM EDT - 7 months ago

Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal

Feb 13, 2025, 8:01 AM EST - 8 months ago

Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025

Feb 12, 2025, 8:11 PM EST - 8 months ago

Aethlon Medical, Inc. (AEMD) Q3 2025 Earnings Call Transcript

Feb 12, 2025, 4:15 PM EST - 8 months ago

Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update

Feb 5, 2025, 8:01 AM EST - 8 months ago

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025

Jan 29, 2025, 8:01 AM EST - 8 months ago

Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial

Dec 20, 2024, 8:01 AM EST - 10 months ago

Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu

Nov 14, 2024, 8:00 AM EST - 11 months ago

Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally

Nov 13, 2024, 7:58 PM EST - 11 months ago

Aethlon Medical, Inc. (AEMD) Q2 2025 Earnings Call Transcript

Nov 13, 2024, 4:15 PM EST - 11 months ago

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

Nov 12, 2024, 8:00 AM EST - 11 months ago

Innovative Medical Technology Advances with First Patient Enrollments

Nov 11, 2024, 8:01 AM EST - 11 months ago

Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia

Nov 6, 2024, 8:01 AM EST - 11 months ago

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024

Oct 8, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit

Sep 19, 2024, 10:00 AM EDT - 1 year ago

Immunotherapy Clinical Trials - A New Approach to Treating Cancer

Sep 19, 2024, 8:01 AM EDT - 1 year ago

Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India

Sep 17, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical to Present at Virtual Investor Conferences in September

Sep 17, 2024, 7:30 AM EDT - 1 year ago

Innovation Driving Cancer's Solid Tumors Market

Sep 16, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial

Sep 13, 2024, 8:35 AM EDT - 1 year ago

Aethlon Medical to Present at the Life Sciences Investor Forum September 19th

Aug 27, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys

Aug 14, 2024, 6:45 PM EDT - 1 year ago

Aethlon Medical, Inc. (AEMD) Q1 2025 Earnings Call Transcript

Aug 14, 2024, 4:15 PM EDT - 1 year ago

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update

Aug 12, 2024, 9:01 AM EDT - 1 year ago

The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

Aug 12, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial

Aug 6, 2024, 9:12 AM EDT - 1 year ago

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024

Jun 27, 2024, 6:37 PM EDT - 1 year ago

Aethlon Medical, Inc. (AEMD) Q4 2024 Earnings Call Transcript

Jun 27, 2024, 4:15 PM EDT - 1 year ago

Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update

Jun 21, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024

Jun 20, 2024, 7:00 AM EDT - 1 year ago

What's Next in Treatments for Cancer Patients with Solid Tumors?

Jun 18, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial

Jun 7, 2024, 8:00 AM EDT - 1 year ago

The Hunt for Virus Treatments Continues Post Covid-19

Jun 3, 2024, 9:05 AM EDT - 1 year ago

Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID

Jun 3, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies

May 15, 2024, 9:15 AM EDT - 1 year ago

Aethlon Medical Announces Pricing of $4.7 Million Public Offering

May 10, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma

Feb 21, 2024, 8:01 AM EST - 1 year ago

Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices

Feb 14, 2024, 9:17 PM EST - 1 year ago

Aethlon Medical, Inc. (AEMD) Q3 2024 Earnings Call Transcript

Vikingsstrade Oct. 3 at 7:34 PM

0 · Reply

DougieFreshPicks Oct. 3 at 5:58 PM

$ELPW $AEMD $FRGT Here is the Night Note penny and small caps from last night 🎯

0 · Reply

smoothest06 Oct. 3 at 3:35 PM

$AEMD

0 · Reply

FCGEnterprises Oct. 3 at 12:08 PM

$AEMD lets go today $1 and up

0 · Reply

smoothest06 Oct. 3 at 1:23 AM

$AEMD

0 · Reply

MoonCowBoy Oct. 3 at 12:43 AM

$AEMD $INAB $OGEN $AGMH :

0 · Reply

Bazzzigar Oct. 2 at 6:58 PM

$AEMD

0 · Reply

1Spartantrade1 Oct. 2 at 6:38 PM

0 · Reply

Condemor Oct. 2 at 5:35 PM

$AEMD watchout if breaks 0.81

0 · Reply

smoothest06 Oct. 2 at 5:24 PM

$AEMD PRESSURE

0 · Reply

3klassic Oct. 2 at 4:05 PM

$AEMD $2 incoming

0 · Reply

Bazzzigar Oct. 2 at 1:05 PM

$AEMD $1+

0 · Reply

Kolawole48 Oct. 1 at 4:09 PM

$AEMD https://www.prnewswire.com/news-releases/aethlon-medical-announces-financial-results-for-the-fiscal-second-quarter-ended-september-30-2024-and-provides-corporate-update-302304742.html

1 · Reply

brandonscience Sep. 30 at 9:13 PM

$AEMD where’s the lab data? i thought we were supposed to get it in September?

0 · Reply

smoothest06 Sep. 30 at 12:18 PM

$AEMD

0 · Reply

Alfred_Penny_worth Sep. 29 at 9:25 PM

$AEMD Warrant reset games being played here. This is toxic AF and not to be touched. Armistice and Intracoastal Capital are some of the biggest scumbags on Wallstreet. https://fintel.io/so/us/aemd https://www.sec.gov/Archives/edgar/data/882291/000168316825006352/aethlon_s1.htm

1 · Reply

smoothest06 Sep. 29 at 12:41 PM

$AEMD

0 · Reply

Stochalicious Sep. 29 at 10:28 AM

$AEMD Bullish trend

0 · Reply

pitkineagle Sep. 28 at 12:01 AM

$AEMD Grok says protein ALK7 is somewhat highly glycosylated. Cornell studies say it travels in the bloodstream and is the engine for pancreatic cancer. Hmmm

1 · Reply

Meri7 Sep. 27 at 6:27 PM

$AEMD is it now it happens?

0 · Reply

MGeronimo Sep. 27 at 10:42 AM

$AEMD ADDING MASSIVE AT .73

0 · Reply

Rote_Trader1018 Sep. 25 at 8:39 PM

$AEMD going to double++ from here. 🌚

0 · Reply

Market Cap	2.08M
Revenue (ttm)	0.00
Net Income (ttm)	-13.39M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	298,500
Avg Vol	3,736,304
Day's Range	N/A - N/A
Shares Out	2.60M
Stochastic %K	72%
Beta	1.82
Analysts	Hold
Price Target	$3.02